APA (7th ed.) Citation

Grisham, R. N., Hopp, E., Pennington, K., Holloway, R., Wenham, R. M., Blecharz, P., . . . Alvero, C. (2026). Phase II clinical trial of nirogacestat in patients with relapsed ovarian granulosa cell tumours. Clinical & Translational Medicine, 16(1), 1. https://doi.org/10.1002/ctm2.70568

Chicago Style (17th ed.) Citation

Grisham, Rachel N., et al. "Phase II Clinical Trial of Nirogacestat in Patients with Relapsed Ovarian Granulosa Cell Tumours." Clinical & Translational Medicine 16, no. 1 (2026): 1. https://doi.org/10.1002/ctm2.70568.

MLA (9th ed.) Citation

Grisham, Rachel N., et al. "Phase II Clinical Trial of Nirogacestat in Patients with Relapsed Ovarian Granulosa Cell Tumours." Clinical & Translational Medicine, vol. 16, no. 1, 2026, p. 1, https://doi.org/10.1002/ctm2.70568.